Why Is There Still No Comprehensive Tick-Borne Illness Blood Panel?

A Growing Public Health Gap Patients Continue Navigating Alone

For many patients, the process of being evaluated for tick-borne illness is far more complicated than most people realize.

A person develops symptoms after a tick bite.

They go to a doctor expecting:

“I’d like to be tested for tick-borne illness.”

What many patients do not realize is that there is currently no single, universally comprehensive blood panel that screens for the full range of major tick-associated illnesses and syndromes patients may potentially encounter.

Instead, patients are often sent through a fragmented maze of separate tests, specialists, referrals, and partial evaluations.

And according to thousands of patient-reported experiences collected through TickBiteData.com, many people spend years navigating that system before finally receiving answers.

The Public Assumption vs. The Clinical Reality

Many people understandably assume there is:

• one “tick disease test”

• one standardized panel

• one clear diagnostic pathway

But the reality is far more fragmented.

Depending on symptoms, region, physician familiarity, and healthcare access, patients may separately require testing for:

• Alpha-gal syndrome (Alpha-gal IgE)

• Lyme disease

• Ehrlichiosis

• Babesiosis

• Rocky Mountain spotted fever

• Bartonella

• Anaplasmosis

• Tularemia

• Powassan virus

• and other region-specific infections

Even major laboratory providers often list these tests individually or within limited disease groupings rather than as part of a unified comprehensive screening framework.

This creates a major issue:

Patients frequently do not know what they should even be asking to be tested for.

A System Built Around Individual Tests

Quest Diagnostics, Labcorp, and other major laboratory systems currently offer numerous separate tick-borne illness tests.

Some providers may order:

• Lyme testing only

• RMSF testing only

• Ehrlichia testing only

• or Alpha-gal testing only

Meanwhile, many patients report symptoms that overlap across multiple categories:

• neurological symptoms

• gastrointestinal symptoms

• cardiovascular symptoms

• inflammatory symptoms

• dermatologic reactions

• chronic fatigue

• dizziness

• brain fog

This creates a situation where patients may:

• receive partial testing

• receive incomplete evaluations

• test for one condition while another goes uninvestigated

• spend years moving between specialists

• assume they were “fully tested” when they were not

Alpha-gal Syndrome Complicates the Picture Further

Alpha-gal syndrome itself creates additional diagnostic complexity.

Many patients report:

• delayed reactions after eating

• fluctuating symptoms

• gastrointestinal symptoms without classic hives

• neurological complaints

• reactions to mammalian-derived products beyond food

And importantly: Alpha-gal testing is not always included in routine allergy panels or standard tick-borne evaluations.

Some patients report spending years undergoing:

• gastrointestinal workups

• cardiology evaluations

• neurological testing

• autoimmune investigations

• psychiatric evaluation

before someone finally orders an Alpha-gal IgE test.

One of the most common phrases repeatedly appearing in patient narratives collected through TickBiteData?

“They told me it was anxiety.”

The Financial Burden of Fragmented Testing

The consequences of fragmented testing are not only medical.

They are financial.

Patients repeatedly describe:

• multiple specialist visits

• repeated emergency room visits

• duplicate testing

• missed work

• medication costs

• out-of-pocket laboratory fees

• repeated imaging studies

• years of healthcare expenses before diagnosis

For many patients, the process becomes physically, emotionally, and financially exhausting.

And because symptoms often overlap with numerous other conditions, patients may spend years being treated symptom-by-symptom rather than being evaluated through a broader tick-borne illness framework.

Why a Comprehensive Tick-Borne Panel Deserves Discussion

This raises an important public health question: Why is there still no broadly recognized comprehensive tick-borne illness blood panel capable of evaluating multiple major tick-associated conditions simultaneously?

A more integrated screening approach could potentially help:

• reduce diagnostic delays

• improve physician awareness

• identify overlapping conditions earlier

• improve patient safety

• reduce repeat testing

• reduce healthcare costs

• improve public health surveillance

• help patients understand what has and has not actually been evaluated

Importantly, no single panel would solve every diagnostic challenge.

Tick-borne illness remains medically complex.

False negatives, timing of testing, regional variation, symptom overlap, and evolving science would still exist.

But a more comprehensive and standardized testing framework could represent a meaningful step forward.

The Data Suggest Patients Are Falling Through the Cracks

Across more than 2,100 U.S. survey responses collected through TickBiteData.com, several recurring themes continue appearing:

• delayed diagnosis

• fragmented care

• incomplete evaluations

• symptom overlap

• repeated specialist referrals

• neurological complaints

• gastrointestinal symptoms

• patients educating healthcare providers about Alpha-gal syndrome themselves

These patterns suggest many patients may still be falling through diagnostic gaps that current healthcare systems are not fully designed to address.

A Public Health Opportunity

This conversation should not be framed as criticism of individual physicians.

Many healthcare professionals are working within:

• time limitations

• evolving research

• fragmented testing systems

• region-specific guidance

• incomplete awareness surrounding emerging tick-associated illness

But the growing number of patient-reported experiences raises an important broader systems-level question: Has the rapid expansion of tick-associated illness outpaced the structure of current diagnostic workflows? And if so, what would a more modern, integrated, patient-centered approach look like?

What Patients Are Asking For

Increasingly, patients are asking for:

• clearer diagnostic pathways

• better physician awareness

• improved Alpha-gal education

• recognition of delayed and non-classic symptoms

• improved understanding of mammalian-derived product exposure

• more integrated tick-borne illness evaluation

• and stronger public health attention overall

At the center of many of these concerns is one simple idea: Patients want a healthcare system that recognizes tick-borne illness earlier, more comprehensively, and with less fragmentation.

Final Thoughts

Tick-borne illness is no longer a niche conversation.

Alpha-gal syndrome awareness continues expanding.

Patients across multiple countries are reporting remarkably similar experiences and many continue describing years of confusion before receiving appropriate evaluation.

The question is no longer whether tick-associated illnesses deserve attention.

The question is whether current diagnostic systems have evolved quickly enough to keep pace with what patients are actually experiencing.

A more comprehensive tick-borne illness testing framework may not solve every challenge but it is a conversation increasingly worth having.

About TickBiteData

TickBiteData.com is an independent patient-reported data initiative focused on observational survey data related to Alpha-gal syndrome and tick-borne illness experiences.

The project aims to support awareness, future research, public health discussion, and improved understanding of real-world patient experiences.

Patient-reported survey data should not be interpreted as establishing clinical causation or replacing medical advice.

www.TickBiteData.com